{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:13:41Z","timestamp":1790082821160,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd000026","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,9,4]],"date-time":"2014-09-04T00:00:00Z","timestamp":1409788800000}}],"reference-count":97,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000026.pub2","type":"journal-article","created":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T03:22:36Z","timestamp":1409887356000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Routine versus selective antifungal administration for control of fungal infections in patients with cancer"],"prefix":"10.1002","volume":"2017","author":[{"given":"Peter C","family":"G\u00f8tzsche","sequence":"first","affiliation":[{"name":"Rigshospitalet; Nordic Cochrane Centre; Blegdamsvej 9, 7811 Copenhagen Denmark DK-2100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle Krogh","family":"Johansen","sequence":"additional","affiliation":[{"name":"Rigshospitalet; The Nordic Cochrane Centre; Blegdamsvej 9, 3343 Copenhagen Denmark DK 2100"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,9,4]]},"reference":[{"key":"10.1002\/14651858.CD000026.pub2-BIB0001|cit1","unstructured":"Acuna G Winston DJ Young LS Ketoconazole prophylaxis of fungal infections in the granulocytopenic patient: a double-blind, randomized controlled trial Program and Abstracts of 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology 1981 abstract 852"},{"issue":"2","key":"10.1002\/14651858.CD000026.pub2-BIB0002|cit2","first-page":"127","article-title":"Does ketoconazole prevent fungal infection in children treated with high dose chemotherapy and bone marrow transplantation? Results of a randomized placebo-controlled trial","volume":"7","author":"Benhamou","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0003|cit3","first-page":"19","article-title":"Results of a randomized double-blind placebo controlled trial with ketoconazole in the prevention of fungal infection in children treated with high dose chemotherapy and BMT [abstract]","volume":"5 Suppl 2","author":"Hartmann","year":"1990","journal-title":"Bone Marrow Transplant"},{"issue":"1-2","key":"10.1002\/14651858.CD000026.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.0954-6820.1978.tb08410.x","article-title":"Prophylactic treatment with miconazole in patients highly predisposed to fungal infection. A placebo-controlled double-blind study","volume":"204","author":"Brincker","year":"1978","journal-title":"Acta Medica Scandinavica"},{"issue":"5","key":"10.1002\/14651858.CD000026.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1439-0507.1983.tb03203.x","article-title":"Prevention of mycosis in granulocytopenic patients with prophylactic ketoconazole treatment","volume":"26","author":"Brincker","year":"1983","journal-title":"Mykosen"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0006|cit6","first-page":"347","article-title":"Antifungal chemoprophylaxis in cancer children: a prospective randomized controlled study","volume":"13","author":"Caselli","year":"1990","journal-title":"Microbiologica"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/0002-9343(89)90441-5","article-title":"Empiric antifungal therapy in febrile granulocytopenic patients","volume":"86","author":"EORTC International Antimicrobial Therapy Cooperative Group","year":"1989","journal-title":"The American Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD000026.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1001\/archinte.1984.00350200054006","article-title":"Infection prophylaxis in acute leukemia. Comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the two","volume":"144","author":"Estey","year":"1984","journal-title":"Archives of Internal Medicine"},{"issue":"8","key":"10.1002\/14651858.CD000026.pub2-BIB0009|cit9","first-page":"1065","article-title":"[Empiric therapy with fluconazole in granulocytopenic patients with carcinoma or leukemia][Japanese]","volume":"47","author":"Fukuda","year":"1994","journal-title":"The Japanese Journal of Antibiotics"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0010|cit10","first-page":"S15","article-title":"Early AmBisome in febrile neutropenia in patients with haematological disorders","volume":"14 Suppl 5","author":"Goldstone","year":"1994","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1002\/14651858.CD000026.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000239184","article-title":"Effect of fluconazole prophylaxis on fever and use of amphotericin in neutropenic cancer patients. Bone Marrow Transplantation Team","volume":"40","author":"Chandrasekar","year":"1994","journal-title":"Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD000026.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jac\/33.2.309","article-title":"The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. Bone Marrow Transplantation Team","volume":"33","author":"Chandrasekar","year":"1994","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0013|cit13","first-page":"645","article-title":"Prophylactic fluconazole and marrow transplantation [correspondence]","volume":"327","author":"Goodman","year":"1992","journal-title":"The New England Journal of Medicine"},{"issue":"13","key":"10.1002\/14651858.CD000026.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD000026.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/archinte.1987.00370040092016","article-title":"Ketoconazole in the prevention of candidiasis in patients with cancer. A prospective, randomized, controlled, double-blind study","volume":"147","author":"Hansen","year":"1987","journal-title":"Archives of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD000026.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/infdis\/147.6.1060","article-title":"Ketoconazole and candidiasis: a controlled study","volume":"147","author":"Hughes","year":"1983","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s10156-002-0207-5","article-title":"Itraconazole is not effective for the prophylaxis of fungal infections in patients with neutropenia","volume":"9","author":"Kaptan","year":"2003","journal-title":"Journal of Infection and Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD000026.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.bmt.1701543","article-title":"Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study","volume":"23","author":"Kelsey","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0019|cit19","first-page":"A10","article-title":"Failure of fluconazole prophylaxis to reduce mortality during treatment for refractory acute myeloid leukemia: a phase III multicenter study [abstract]","volume":"73 Suppl 2","author":"Kern","year":"1996","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0020|cit20","first-page":"A52, abstract 2","article-title":"Failure of fluconazole prophylaxis to reduce mortality during treatment for refractory acute myleoid leukemia: results of a phase III multicenter study","volume":"74 Suppl 1","author":"Kern","year":"1997","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<291::AID-CNCR13>3.0.CO;2-O","article-title":"Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group","volume":"83","author":"Kern","year":"1998","journal-title":"Cancer"},{"issue":"2","key":"10.1002\/14651858.CD000026.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/515129","article-title":"Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto","volume":"28","author":"Menichetti","year":"1999","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0023|cit23","first-page":"LM","article-title":"Antifungal prophylaxis in neutropenic pts (<1000\/mmc) with haematological malignancy: a double-blind trial to compare itraconazole oral solution (IOS) with placebo (PLA)","volume":"abstract","author":"Favero","year":"1997","journal-title":"37th Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC); 28 Sept-1 Oct 1997; Toronto"},{"issue":"2","key":"10.1002\/14651858.CD000026.pub2-BIB0025|cit24","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1086\/313654","article-title":"A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients","volume":"30","author":"Nucci","year":"2000","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0024|cit25","unstructured":"Nucci M Biasoli I Akiti T Silveira F Solza C Barreiros G A double-blind, randomized placebo-controlled trial of itraconazole capsules for antifungal prophylaxis in neutropenic patients The Tenth International Symposium on Infections in the Immunocompromised Host. Davos, Switzerland, 21-24 June 1998 International Immunocompromised Host Society 1998 Abstract 104"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0026|cit26","unstructured":"Nucci M Biasoli I Solza C Silveira F Akiti T Derossi A Itraconazole capsules versus placebo in the prophylaxis of fungal infections in neutropenic cancer patients: a double-blind, randomized study Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), 38th Meeting, San Diego, Sept 24-27 1998 1998 480 (Abstract J-102)"},{"issue":"4","key":"10.1002\/14651858.CD000026.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2796.1992.tb00945.x","article-title":"Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukaemia in adults: more bacteraemias","volume":"231","author":"Palmblad","year":"1992","journal-title":"Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0028|cit28","doi-asserted-by":"crossref","unstructured":"Penack O Schwartz S Martus P Reinwald M Schmidt-Hieber M Thiel E A randomized phase III trial of low dose liposomal amphotericin B (L-AmB) as prophylaxis of invasive fungal infections (IFI) in neutropenic patients (pts) Blood Proceedings of the 47th Annual Meeting of the American Society of Hematology; 10-13 December, 2005; Atlanta, Georgia 2005 Abstract No. 82","DOI":"10.1182\/blood.V106.11.82.82"},{"issue":"8","key":"10.1002\/14651858.CD000026.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/annonc\/mdl128","article-title":"Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial","volume":"17","author":"Penack","year":"2006","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0030|cit30","first-page":"0376","article-title":"Low dose liposomal amphotericin B (L-AMB) as prophylaxis of invasive fungal infections in patients (pts) with prolonged neutropenia: preliminary results of a randomized phase III trial","volume":"abstract","author":"Penack","year":"2005","journal-title":"10th Congress of the European Hematology Association"},{"issue":"5","key":"10.1002\/14651858.CD000026.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/infdis\/165.5.891","article-title":"Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients","volume":"165","author":"Perfect","year":"1992","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0032|cit32","unstructured":"Pizzo PA Robichau KJ Simon R Empiric antifungal therapy for cancer patients with prolonged fever and granulocytopenia Proceedings of the American Association of Cancer Research 1980 348 (Abstract C-115)"},{"issue":"1","key":"10.1002\/14651858.CD000026.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9343(82)90594-0","article-title":"Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia","volume":"72","author":"Pizzo","year":"1982","journal-title":"The American Journal of Medicine"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0034|cit34","unstructured":"Riley D Beatty P Pavia A Evans TG Prophylactic use of low-dose amphotericin B (AMB) in bone marrow transplant (BMT) patients 32nd Interscience Conference of Antimicrobial Agents and Chemotherapy. American Society for Microbiology, 1992 1992 abstract 620"},{"issue":"6","key":"10.1002\/14651858.CD000026.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0002-9343(94)90345-X","article-title":"The prophylactic use of low-dose amphotericin B in bone marrow transplant patients","volume":"97","author":"Riley","year":"1994","journal-title":"The American Journal of Medicine"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0036|cit36","first-page":"LM","article-title":"The impact of fluconazole (F) prophylaxis on fungal colonization and subsequent infection in cancer neutropenic patients","volume":"abstract","author":"Laverdiere","year":"1997","journal-title":"37th Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC); 28 Sept-1 Oct 1997; Toronto"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/jac\/46.6.1001","article-title":"Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients","volume":"46","author":"Laverdiere","year":"2000","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD000026.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/515128","article-title":"Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group","volume":"28","author":"Rotstein","year":"1999","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD000026.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/infdis\/172.4.1035","article-title":"Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias","volume":"172","author":"Schaffner","year":"1995","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0040|cit40","unstructured":"Siegel M Murphy M Counts GW Meyers JD Prophylactic ketoconazole for the prevention of fungal infection in bone marrow transplant patients 23rd Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC). American Society for Microbiology 1982 abstract 166"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood.V96.6.2055","article-title":"Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial","volume":"96","author":"Marr","year":"2000","journal-title":"Blood"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0042|cit42","unstructured":"Slavin M Bowden R Osborne B Adams R Levenstein M Feldman A Fluconazole prophylaxis in marrow transplant recipients: a randomized placebo controlled double blind study 32nd Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC). American Society for Microbiology 1992 abstract 623"},{"issue":"6","key":"10.1002\/14651858.CD000026.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a prospective, randomized, double-blind study","volume":"171","author":"Slavin","year":"1995","journal-title":"The Journal of Infectious Diseases"},{"issue":"7","key":"10.1002\/14651858.CD000026.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.bbmt.2007.03.005","article-title":"Fluconazole coadministration concurrent with cyclophosphamide conditioning may reduce regimen-related toxicity postmyeloablative hematopoietic cell transplantation","volume":"13","author":"Upton","year":"2007","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD000026.pub2-BIB0045|cit45","first-page":"195","article-title":"[A co-operative study on prophylaxis of fungal infection in patients with hematological diseases: prophylactic effect of oral administration of amphotericin B][Japanese]","volume":"21","author":"Suda","year":"1980","journal-title":"[Rinsho Ketsueki] The Japanese Journal of Clinical Hematology"},{"issue":"3","key":"10.1002\/14651858.CD000026.pub2-BIB0046|cit46","first-page":"1833","article-title":"Fungal prophylaxis with AmBisome in liver and bone marrow transplant recipients: results of two randomized double-blind studies","volume":"26","author":"Tollemar","year":"1994","journal-title":"Transplantation Proceedings"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD000026.pub2-BIB0048|cit47","first-page":"1495","article-title":"Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: a randomized trial in bone marrow transplant recipients","volume":"25","author":"Tollemar","year":"1993","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"10.1002\/14651858.CD000026.pub2-BIB0049|cit48","first-page":"577","article-title":"Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients","volume":"12","author":"Tollemar","year":"1993","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0047|cit49","first-page":"S151","article-title":"Double-blind randomized trials with AmBisome (TM) as prophylaxis in bone marrow and liver transplant patients","volume":"12 Suppl 4","author":"Tollemar","year":"1993","journal-title":"Bone Marrow Transplantation"},{"issue":"5-6","key":"10.1002\/14651858.CD000026.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/10428199309067926","article-title":"Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study","volume":"11","author":"Vreugdenhil","year":"1993","journal-title":"Leukemia & Lymphoma"},{"issue":"6","key":"10.1002\/14651858.CD000026.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0002-9343(87)90949-1","article-title":"Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole","volume":"83","author":"Wingard","year":"1987","journal-title":"The American Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD000026.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.bmt.1701543","article-title":"Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study","volume":"23","author":"Kelsey","year":"1999","journal-title":"Bone Marrow Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD000026.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7326\/0003-4819-118-7-199304010-00003","article-title":"Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial","volume":"118","author":"Winston","year":"1993","journal-title":"Annals of Internal Medicine"},{"issue":"835","key":"10.1002\/14651858.CD000026.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/pgmj.71.835.284","article-title":"Prophylactic use of fluconazole in neutropenic cancer patients","volume":"71","author":"Yamac","year":"1995","journal-title":"Postgraduate Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD000026.pub2-BIB0055|cit55","first-page":"127","article-title":"Does ketoconazole prevent fungal infection in children treated with high dose chemotherapy and bone marrow transplantation? Results of a randomized placebo-controlled trial","volume":"7","author":"Benhamou","year":"1991","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0056|cit56","first-page":"24","article-title":"Prophylaxis of candidiasis in cancer patients","volume":"7 Suppl 6","author":"Bodey","year":"1990","journal-title":"Seminars in Oncology"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0057|cit57","unstructured":"Brincker H Personal communication; unpublished study on fluconazole 1990"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2141.2012.09156.x","article-title":"A prospective, randomized study of empirical antifungal therapy for the treatment of chemotherapy-induced febrile neutropenia in children","volume":"158","author":"Caselli","year":"2012","journal-title":"British Journal of Haematology"},{"issue":"3","key":"10.1002\/14651858.CD000026.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/jama.1979.03300030030016","article-title":"Oral amphotericin for candidiasis in patients with hematologic neoplasms. An autopsy study","volume":"242","author":"Ezdinli","year":"1979","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD000026.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/1097-0142(19910701)68:1<9::AID-CNCR2820680103>3.0.CO;2-U","article-title":"Antifungal treatment by amphotericin B and 5-fluorocytosine delays the recovery of normal hematopoietic cells after intensive cytostatic therapy for acute myeloid leukemia","volume":"68","author":"Hiddemann","year":"1991","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0061|cit61","doi-asserted-by":"crossref","unstructured":"Prentice AG Bradford GR Prophylaxis of fungal infections with itraconazole during remission-induction therapy Mycoses 1989 96-102 (describes an unpublished study)","DOI":"10.1111\/j.1439-0507.1989.tb02298.x"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0062|cit62","first-page":"465, abstract 1","article-title":"Interim analysis of fluconazole (flu), intermittent amphotericin (ampho) and no treatment (ntx) for prophylaxis of fungal disease in bone marrow transplant (bmt) and acute leukemia (al) patients (pts)","volume":"12","author":"Reed","year":"1993","journal-title":"Proceedings of the Annual Meeting of the American Society of Clinical Oncology"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1093\/clinids\/12.Supplement_3.S369","article-title":"Prophylaxis of oropharyngeal candidiasis with fluconazole","volume":"12 Suppl 3","author":"Samonis","year":"1990","journal-title":"Reviews of Infectious Diseases"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.1990.tb07931.x","article-title":"Prevention of gram-positive and Candida albicans infections using teicoplanin and fluconazole: a randomized study in neutropenic children","volume":"76 Suppl 2","author":"Schaison","year":"1990","journal-title":"British Journal of Haematology"},{"issue":"3","key":"10.1002\/14651858.CD000026.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s15010-006-5113-9","article-title":"A prospective, randomized multicenter trial of the empirical addition of antifungal therapy for febrile neutropenic cancer patients: results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II","volume":"34","author":"Schiel","year":"2006","journal-title":"Infection"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0066|cit66","unstructured":"Siegel M Murphy M Counts GW Meyers JD Prophylactic ketoconazole for the prevention of fungal infection in bone marrow transplant patients 23rd Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC). American Society for Microbiology, 1982 1982 abstract 166"},{"issue":"5","key":"10.1002\/14651858.CD000026.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jinf.2007.07.003","article-title":"A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML)","volume":"55","author":"Vehreschild","year":"2007","journal-title":"Journal of Infection"},{"issue":"4","key":"10.1002\/14651858.CD000026.pub2-BIB0068|cit68","first-page":"389","article-title":"A controlled clinical trial of itraconazole for prevention of fungal infections secondary to chemotherapy","volume":"23","author":"Wang","year":"2003","journal-title":"Di Yi Jun Yi Da Xue Xue Bao [Academic Journal of the First Medical College of PLA]"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0069|cit69","unstructured":"Cornely OA B\u00f6hme A Vehreschild JJ Buchheidt D Arenz D Harnischmacher U Evaluating voriconazole (VCZ) as primary antifungal prophylaxis during induction chemotherapy for acute myelogenous leukemia (AML) 46th Interscience Conference on Antimicrobial Agents and Chemotherapy; 2006 Sept 27-30; San Francisco"},{"issue":"9270","key":"10.1002\/14651858.CD000026.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(00)04891-1","article-title":"Congestive heart failure associated with itraconazole","volume":"357","author":"Ahmad","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/01621459.1989.10478782","article-title":"An assessment of publication bias using a sample of published clinical trials","volume":"84","author":"Berlin","year":"1989","journal-title":"Journal of the American Statistical Association"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/sim.4780120517","article-title":"Interim analyses, stopping rules and data monitoring in clinical trials in Europe","volume":"2","author":"Buyse","year":"1993","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jama.1990.03440100121018","article-title":"Underreporting research is scientific misconduct","volume":"263","author":"Chalmers","year":"1990","journal-title":"JAMA"},{"issue":"20","key":"10.1002\/14651858.CD000026.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1001\/jama.291.20.2457","article-title":"Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles","volume":"291","author":"Chan","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2288-6-40","article-title":"Fungal infection-related mortality versus total mortality as an outcome in trials of antifungal agents","volume":"6","author":"Due","year":"2006","journal-title":"BioMed Central Medical Research Methodology"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood.V60.2.309.309","article-title":"Causes of initial remission induction failure in acute myelogenous leukemia","volume":"60","author":"Estey","year":"1982","journal-title":"Blood"},{"issue":"5","key":"10.1002\/14651858.CD000026.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF00558064","article-title":"Multiple publication of reports of drug trials","volume":"36","author":"G\u00f8tzsche","year":"1989","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0140-6736(96)91115-0","article-title":"Pharmaceutical company trials and the integrity of medical research (letter)","volume":"347","author":"Huston","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/1097-0142(197402)33:2<568::AID-CNCR2820330236>3.0.CO;2-2","article-title":"Causes of death in cancer patients","volume":"33","author":"Inagaki","year":"1974","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1001\/jama.282.18.1752","article-title":"Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis","volume":"282","author":"Johansen","year":"1999","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD000026.pub2-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000969","article-title":"Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia","author":"Johansen","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD000026.pub2-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000239","article-title":"Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients","author":"Johansen","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD000026.pub2-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002033","article-title":"Nystatin prophylaxis and treatment in severely immunodepressed patients","author":"Johansen","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD000026.pub2-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004707","article-title":"Voriconazole versus amphotericin B in cancer patients with neutropenia","author":"J\u00f8rgensen","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0085|cit85","first-page":"10","article-title":"Fungal infections in bone marrow transplant patients","volume":"17","author":"Meyers","year":"1990","journal-title":"Seminars in Oncology"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/bjc.1978.284","article-title":"Size of cancer clinical trials and stopping rules","volume":"38","author":"Pocock","year":"1978","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias, dimension of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1200\/JCO.1986.4.10.1529","article-title":"Publication bias: the case for an international registry of clinical trials","volume":"4","author":"Simes","year":"1986","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"10.1002\/14651858.CD000026.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00007611-198607000-00020","article-title":"Clinical experience with amphotericin B in acute myelogenous leukemia","volume":"79","author":"Stein","year":"1986","journal-title":"Southern Medical Journal"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/bmj.315.7109.640","article-title":"Publication bias: evidence of delayed publication in a cohort study of clinical research projects","volume":"315","author":"Stern","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0091|cit91","first-page":"177","article-title":"Candida infections in bone marrow transplant recipients","volume":"8","author":"Verfaillie","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0092|cit92","first-page":"43","article-title":"Role of surveillance cultures in prevention and treatment of fungal infections","volume":"9","author":"Walsh","year":"1990","journal-title":"Journal of National Cancer Institute Monographs"},{"issue":"3","key":"10.1002\/14651858.CD000026.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/clinids\/13.3.496","article-title":"Empiric therapy with amphotericin B in febrile granulocytopenic patients","volume":"13","author":"Walsh","year":"1991","journal-title":"Reviews of Infectious Diseases"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/jac\/36.6.899","article-title":"Antifungal drug susceptibility testing","volume":"36","author":"Working Party of the British Society for Antimicrobial Chemotherapy","year":"1995","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD000026.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1136\/bmj.314.7089.1238","article-title":"Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia","volume":"314","author":"G\u00f8tzsche","year":"1997","journal-title":"BMJ"},{"issue":"2.","key":"10.1002\/14651858.CD000026.pub2-BIB0096|cit96","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000026","article-title":"Routine versus selective antifungal administration for control of fungal infections in patients with cancer (Cochrane Review)","author":"G\u00f8tzsche","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD000026.pub2-BIB0097|cit97","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000026","article-title":"Routine versus selective antifungal administration for control of fungal infections in patients with cancer","author":"G\u00f8tzsche","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD000026.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T07:06:32Z","timestamp":1717311992000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD000026.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,4]]},"references-count":97,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000026.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,4]]}}}